PTEN与ERG在前列腺癌中的临床效用与生物学意义
该系统综述通过PubMed检索评估PTEN和ERG在前列腺癌发病机制中的研究。研究显示ERG预后意义结果不一致,PTEN与ERG可能共存但协同致癌功能尚未确证,PTEN突变与一系列预后特征相关,但其实际临床效用仍有待确定。
要点
- PTEN和ERG突变在前列腺癌中常见,但人类研究结论尚不一致。
- 同时检测PTEN与ERG的研究发现两基因可能共存,协同致癌功能未确证。
- PTEN突变与一系列预后特征相关,实际临床效用仍待确定。
核心结论
- PTEN与ERG在前列腺癌中的协同致癌功能尚未得到确证,PTEN突变的实际临床效用仍待确定。
研究设计与样本
- 系统PubMed检索纳入评估PTEN和ERG在前列腺癌中发病机制的原著文章。
主要发现
- 检测ERG预后意义的研究结果存在冲突。
- 同时检测PTEN与ERG的研究发现两基因可能共存,但协同致癌功能尚未确证。
- PTEN突变与一系列预后特征相关,但该信息的实际临床效用仍待确定。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Phosphatase and tensin homolog (PTEN) and ETS-related gene (ERG) mutations are commonly found in prostate cancer. Although mouse studies have demonstrated that PTEN and ERG cooperatively interact during tumorigenesis, human studies examining these genes have been inconclusive. A systematic PubMed search including original articles assessing the pathogenesis of PTEN and ERG in prostate cancer was performed. Studies examining ERG's prognostic significance have conflicting results. Studies examining PTEN and ERG simultaneously found these genes are likely to occur together, but cooperative tumorigenesis functions have not been conclusively established. PTEN mutations are associated with a range of prognostic features. However, the practical clinical utility of this information remains to be determined.
引用
- Ullman D, Dorn D, Rais-Bahrami S, et al. Clinical Utility and Biologic Implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer. Urology. 2017. PMID: 29225123. doi:10.1016/j.urology.2017.11.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。